BTTX

Better Therapeutics
BTTX

 

About: Better Therapeutics Inc is a prescription digital therapeutics company developing a novel form of cognitive behavioural therapy to address the root causes of cardiometabolic diseases. The company has developed a proprietary platform for the development of FDA-regulated, software-based solutions for type 2 diabetes, heart disease and other conditions.

Employees: 54

0
Funds holding %
of 6,656 funds
Analysts bullish %
News positive %

Fund manager confidence

Based on 2023 Q4 SEC filings by fund managers ($100M+ AUM)

500% more first-time investments, than exits

New positions opened: 6 | Existing positions closed: 1

29% more funds holding

Funds holding: 17 [Q3] → 22 (+5) [Q4]

20% more repeat investments, than reductions

Existing positions increased: 6 | Existing positions reduced: 5

3.25% less ownership

Funds ownership: 6.2% [Q3] → 2.95% (-3.25%) [Q4]

70% less capital invested

Capital invested by funds: $925K [Q3] → $281K (-$644K) [Q4]

Research analyst outlook

We haven’t received any recent analyst ratings for BTTX.

Financial journalist opinion